Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-07-04T22:57:01.441Z Has data issue: false hasContentIssue false

3 - Pathology of hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma

Published online by Cambridge University Press:  04 August 2010

Hero K. Hussain
Affiliation:
University of Michigan Medical School, Ann Arbor
Isaac R. Francis
Affiliation:
University of Michigan Medical School, Ann Arbor
Get access

Summary

As with any organ or organ system, the liver is the site of a wide variety of neoplasms, both benign and malignant. Overall, the most common primary neoplasm in the liver is the hemangioma, a benign vascular neoplasm that rarely causes diagnostic difficulty. Primary malignant neoplasms include hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), sarcomas, and an assortment of rare tumors of other types. In adults, the two most common primary malignant tumors are HCC and CCA. Some tumors are mixtures of the two. These two common malignancies will be the topics of the following discussion.

Hepatocellular carcinoma

HCC is a malignant tumor of hepatocytes occurring most commonly in older adults, and is associated with several etiologic factors, including hepatitis B and C, and cirrhosis resulting from steatohepatitis, hemochromatosis, and other causes. Pathologic evaluation of HCC may occur as part of an initial diagnosis when a liver biopsy or fine-needle aspiration (FNA) may yield limited material for study, or when tumors are resected.

Macroscopic features

HCC are typically present within cirrhotic livers, in which they develop fibrous capsules and fibrous intratumoral septae as they enlarge, giving them a firm consistency. Necrosis and intratumoral hemorrhage may be present (Figure 3.1). Satellite nodules may be present at the periphery of large tumors. In non-cirrhotic livers, HCC tends to be softer and unencapsulated. Although one large mass is characteristic, some patients present with several or multiple masses throughout the liver. Multiple small HCC may be difficult to distinguish from nodules of cirrhosis.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ishak, KG, Goodman, ZD, and Stocker, JT. Tumors of the liver and intrahepatic bile ducts. In Armed Forces Institute of Pathology, Atlas of Tumor Pathology, Third Series, Fascicle 31. Washington, DC: American Registry of Pathology, 1999; 199: 203–43.Google Scholar
Hamilton, SR, and Aaltonen, . Pathology and genetics of tumours of the digestive system. In World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer Press, 2000; 163–66.Google Scholar
Matsuura, S, Aishima, S, Taguchi, K, et al. ‘Scirrhous’ type hepatocellular carcinomas: A special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology 2005; 47: 382–90.CrossRefGoogle ScholarPubMed
Kurogi, M, Nakashima, O, Miyaaki, H, Fujimoto, M, and Kojiro, M. Clinicopathological study of scirrhous hepatocellular carcinoma. J Gastroenterol Hepatol 2006; 21: 1470–7.Google ScholarPubMed
Libbrecht, L, Severi, T, Cassiman, D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006; 30: 1405–11.CrossRefGoogle ScholarPubMed
Kakar, S, Gown, A, Goodman, ZD, and Ferrell, LD. Best practices in diagnostic immunohistochemistry. Hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med. 2007; 131: 1648–54.Google ScholarPubMed
Coston, W, Loera, S, Lau, SK, et al. Distinction of hepatocellular carcinoma from benign hepatic mimickers using glypican-3 and CD34 immunohistochemistry. Am J Surg Pathol 2008; 32: 433–44.CrossRefGoogle ScholarPubMed
Lau, SK, Prakash, S, Geller, SA, and Alsabeh, R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002; 33: 1175–81.CrossRefGoogle ScholarPubMed
Wang, L, Vuolo, M, Suhrland, MJ, and Schlesinger, K. HepPar1, MOC-31, pCEA, mCEA, and CD10 for distinguishing hepatocellular carcinoma vs metastatic adenocarcinoma in liver fine needle aspirates. Acta Cytol 2006; 50: 257–62.CrossRefGoogle ScholarPubMed
Chu, PG, Ishizawa, S, Wu, E, and Weiss, L. Hepatocyte antigen as a marker of hepatocellular carcinoma: An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002; 26: 978–88.CrossRefGoogle ScholarPubMed
Morrison, C, Marsh, W, and Frankel, WL. A comparison of CD10 to pCEA, MOC-31, and Hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002; 15: 1279–87.CrossRefGoogle ScholarPubMed
Wee, A. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics. Appl Immunohistochem Mol Morphol 2006; 14: 266–72.CrossRefGoogle ScholarPubMed
Kuo, FY, Chen, WJ, Lu, SN, Wang, JH, and Eng, HL. Fine needle aspiration cytodiagnosis of liver tumors. Acta Cytol 2004; 48: 142–8.CrossRefGoogle ScholarPubMed
DeMay, RM. The Art and Science of Cytopathology. Chicago: ASCP Press, 1996; 1028–30.Google Scholar
Boer, WB, Segal, A, Frost, FA, and Sterrett, GF. Cytodiagnosis of well differentiated hepatocellular carcinoma. Can indeterminate diagnoses be reduced?Cancer Cytopathol 1999; 87: 270–7.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Shaib, Y and El-Serag, HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115–25.CrossRefGoogle ScholarPubMed
Torbenson, M, Yeh, MM, and Abraham, SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol 2007; 31: 1410–13.CrossRefGoogle ScholarPubMed
Ishak, KG, Goodman, ZD, and Stocker, JT. Tumors of the liver and intrahepatic bile ducts. In Armed Forces Institute of Pathology, Atlas of Tumor Pathology, Third Series, Fascicle 31. Washington, DC: American Registry of Pathology, 1999; 250–7.Google Scholar
Hamilton, SR and Aaltonen, . Pathology and genetics of tumours of the digestive system. In World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer Press, 2000; 175–7.Google Scholar
Sasaki, M, Nakamuma, Y, Shimizu, K, and Izumi, R. Pathological and immunohistochemical findings in a case of mucinous cholangiocarcinoma. Pathol Int 1995; 45: 781–6.CrossRefGoogle Scholar
Jeng, Y-M, Chen, C-L, and Hsu, H-C. Lymphoepithelioma-like cholangiocarcinoma: An Epstein-Barr virus-associated tumor. Am J Surg Pathol 2001; 25: 516–20.CrossRefGoogle ScholarPubMed
Adachi, S, Morimoto, O, and Kobayashi, T. Case report. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV. Pathol Int 2008; 58: 69–74.CrossRefGoogle Scholar
Haas, S, Gutgemann, I, Wolff, M, and Fischer, H-P. Intrahepatic clear cell cholangiocarcinoma: Immunohistochemical aspects in a very rare type of cholangiocarcinoma. Am J Surg Pathol 2007; 31: 902–6.CrossRefGoogle Scholar
Shimada, M, Takenaka, K, Rikimaru, T, et al. Characteristics of sarcomatous cholangiocarcinoma of the liver. Hepato-Gastroenterology 2000; 47: 956–61.Google ScholarPubMed
Sasaki, A, Kawano, K, Aramaki, M, Nakashima, K, Yoshida, T, and Kitano, S. Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver. J Surg Oncol 1999; 70: 103–8.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Shimonishi, T, Miyazaki, K, and Nakanuma, Y. Cytokeratin profile relates to histological subtypes and intrahepatic location of the intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 2000; 37: 55–63.CrossRefGoogle ScholarPubMed
Aishima, S, Asayama, Y, Taguchi, K, et al. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Mod Pathol 2002; 15: 1181–90.CrossRefGoogle ScholarPubMed
DeMay, RM. The Art and Science of Cytopathology. Chicago: ASCP Press, 1996; 1034.Google Scholar
Hamilton, SR and Aaltonen, . Pathology and genetics of tumours of the digestive system. In World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer Press, 2000; 181.Google Scholar
Jarnagin, WR, Weber, S, Tickoo, SK, et al. Combined hepatocellular and cholangiocarcinoma: Demographic, clinical, and prognostic factors. Cancer 2002; 94(7): 2040–6.CrossRefGoogle ScholarPubMed
Portolani, N, Baiocchi, GL, Goniglio, A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: A Western experience. Ann Surg Oncol 2008; 15: 1880–90.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×